Saturday 17 October 2026 Export PNTG’s income statement to Excel — free account

The Pennant Group, Inc.

The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.8%, EPS grew 23.8%, free cash flow fell 50.9% and total debt rose 433.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

41.80 0.47 −1.11%

Follow PNTG

Alert me

Market cap: $1.5B
P/E: 44.5×
Fwd P/E: 26.9×
Dividend yield: —
F-score: 5/9
Altman Z: 2.29
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.69

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	1	—	2	3	—	—

Insider Ownership 4.75%

Capital & Financial Ratios $m

Market Cap 1,480.00

Revenue 1,101.71

Net Income 38.45

Free Cash Flow 34.68

Net Debt 182.23

Current Ratio 1.20

Debt/Equity 0.49

P/E ratio 44.47

Fwd P/E 26.90

P/S ratio 1.32

P/B ratio 3.60

Past 5Y EPS Growth 10.07%

This Y EPS Growth 18.28%

Next Y EPS Growth 13.51%

Next Y revenue growth 24.93%

Next 5Y EPS Growth 16.07%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 43.70%

10-year low 10-year high

P/S against its own 10 years 61.94%

10-year low 10-year high

P/B against its own 10 years 47.88%

10-year low 10-year high

EV/Sales against its own 10 years 58.61%

10-year low 10-year high

EV/FCF against its own 10 years 64.81%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	6	24	17	15
Receivables	61	81	123	133
Inventory	—	—	—	—
Other	—	—	—	—
	80	123	167	184

	2023	2024	2025	Q'26
Payables	11	19	25	26
ST’ Debt	—	—	5	5
Other	—	—	—	—
	72	102	147	152

Compound Annual Growth %

	10y	5y	3y
Sales	—	19.37%	26.05%
Cash Flow	—	(0.77%)	74.79%
Earnings	—	13.44%	64.51%
Book Value	—	29.90%	43.88%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	285	298	—	—	—
’25	210	220	229	289	948
’24	157	169	181	189	695
’23	126	132	140	146	545
’22	114	116	118	125	473
’21	106	110	112	112	440
’20	92	93	98	108	391

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(3)	22	—	—	—
’25	(21)	35	14	21	48
’24	1	10	8	21	39
’23	9	7	12	5	33
’22	(4)	9	8	(4)	9
’21	(7)	(5)	(1)	(5)	(18)
’20	2	41	10	(3)	50

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(9)	15	—	—	—
’25	(23)	32	10	17	36
’24	(3)	9	7	17	30
’23	7	5	11	3	25
’22	(6)	3	6	(8)	(5)
’21	(8)	(6)	(3)	(7)	(25)
’20	(1)	38	8	(2)	43

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	0.24	0.25	—	—	—
’25	0.22	0.20	0.17	0.24	0.84
’24	0.16	0.18	0.20	0.16	0.70
’23	0.06	0.09	0.15	0.14	0.44
’22	0.03	(0.09)	0.16	0.12	0.22
’21	0.03	0.09	0.04	(0.08)	0.09
’20	0.10	0.15	0.15	0.13	0.52

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	6.15	9.40	17.52	8.68	10.00	13.77	21.18	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	35.99	66.62	69.56	24.23	16.39	37.13	30.46
People
People	Employees	—	—	—	—	5,223	6,441	5,335	5,791	7,000	9,700
	Revenue/emp, $m	0.00	0.00	0.00	0.00	0.07	0.07	0.09	0.09	0.10	0.10
Income, $m
Income, $m	Revenue	217	251	286	339	391	440	473	545	695	948
	Gross margin, %	11.71	12.91	14.84	13.18	14.04	11.05	12.38	12.30	13.49	13.77
	EBT	13	15	21	5	18	3	9	20	31	46
	EBT margin, %	5.98	6.14	7.21	1.55	4.58	0.62	1.88	3.59	4.51	4.81
	Net income	8	10	16	3	16	2	7	14	24	34
	Depreciation	3	3	3	4	5	5	5	6	7	9
Per share, $
Per share, $	Revenue	7.76	9.02	10.28	12.16	13.95	15.48	16.28	18.25	22.29	27.42
	Earnings	0.28	0.36	0.58	0.11	0.56	0.09	0.23	0.45	0.72	0.86
	Cash flow	0.59	0.62	0.84	0.34	1.79	(0.64)	0.31	1.11	1.26	1.40
	Capex	0.00	(0.09)	(0.13)	(0.24)	(0.26)	(0.22)	(0.49)	(0.27)	(0.29)	(0.35)
	Free cash flow	0.59	0.53	0.71	0.10	1.53	(0.86)	(0.18)	0.84	0.97	1.05
	Book value	0.00	0.00	2.35	2.55	3.61	4.02	4.32	4.87	10.00	10.83
	Shares, m	28	28	28	28	28	28	29	30	31	35
Valuation, ×
Valuation, ×	P/E	37.31	37.31	37.31	312.57	101.86	288.50	46.87	31.56	36.83	32.36
	P/S	1.30	1.30	1.30	2.72	4.16	1.49	0.66	0.78	1.19	1.03
	P/B	4.98	4.98	4.98	12.95	16.09	5.74	2.49	2.91	2.65	2.60
	EV/Sales	2.05	2.05	2.05	2.81	4.22	1.63	0.83	0.91	1.54	1.19
	EV/FCF	47.09	47.09	47.09	334.86	38.41	(29.27)	(76.23)	19.94	35.40	31.16
Cash, $m
Cash, $m	Operating cash flow	16	17	23	10	50	(18)	9	33	39	48
	Capex	(3)	(3)	(4)	(7)	(7)	(6)	(14)	(8)	(9)	(12)
	Free cash flow	16	15	20	3	43	(25)	(5)	25	30	36
Balance, $m
Balance, $m	Working capital	—	0	0	(13)	(29)	4	4	9	21	20
	Total debt	—	—	—	31	22	67	80	64	—	174
	Net debt	—	0	0	30	22	62	77	58	(24)	157
	Shareholders’ equity	—	—	65	71	101	114	126	146	312	374
Returns, %
Returns, %	ROA	0.00	10.58	31.96	0.93	3.30	0.52	1.27	2.54	3.70	3.59
	ROIC	—	0.00	19.76	3.49	9.57	1.66	3.92	7.73	8.28	6.11
	ROE	0.00	17.80	26.08	3.73	18.28	2.50	5.54	9.87	9.86	8.62

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
ARDT Ardent Health, Inc.	$1.7B	21.7×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
SNDA Sonida Senior Living, Inc.	$1.7B	— (loss-making)	— (loss-making)	+122.02% (above 0%: growing)	n/m	−291.70% (below 0%: shrinking)	34.97%	(2.63%)	Compare
CMPS COMPASS Pathways PLC Sponsored ADR	$1.6B	— (loss-making)	—	—	n/m	−4.18% (below 0%: shrinking)	—	0.00%	Compare
AMN AMN Healthcare Services Inc	$1.6B	15.0×	31.2×	+2.29% (above 0%: growing)	n/m	−389.43% (below 0%: shrinking)	30.58%	4.00%	Compare
AGL Agilon Health, Inc.	$1.5B	— (loss-making)	— (loss-making)	+7.15% (above 0%: growing)	n/m	−50.19% (below 0%: shrinking)	7.17%	0.79%	Compare
PNTG The Pennant Group, Inc.	$1.5B	44.5×	26.9×	+35.76% (above 0%: growing)	+23.81% (above 0%: growing)	−50.94% (below 0%: shrinking)	14.07%	5.77%
HCSG Healthcare Services Group, Inc.	$1.5B	12.2×	19.2×	+2.69% (above 0%: growing)	n/m	−26.02% (below 0%: shrinking)	15.89%	4.72%	Compare
NUTX Nutex Health Inc.	$1.4B	7.1×	6.3×	−13.62% (below 0%: shrinking)	n/m	+19.44% (above 0%: growing)	67.04%	57.75%	Compare
USPH U.S. Physical Therapy, Inc.	$1.3B	504×	27.7×	+8.47% (above 0%: growing)	−56.90% (below 0%: shrinking)	−8.24% (below 0%: shrinking)	19.59%	10.25%	Compare
Median of peers	$1.5B	15.0×	19.2×	+2.69%	—	−17.13%	30.58%	3.72%

All 55 Medical Care Facilities stocks →

The Pennant Group, Inc. (PNTG) key facts

Strength: The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
Strength: Net income was $33.8 million, or $0.86 per share (basic), a net margin of 3.12%.
The Pennant Group, Inc. (PNTG) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, PNTG traded at $41.80, a market capitalization of $1.5 billion.
At that price the stock trades at 44.5× trailing-twelve-month earnings and 1.3× sales; its P/E is higher than 44% of its own readings over the past ten years.
Return on equity was 8.62% and debt-to-equity 0.49.
Its Piotroski F-score is 5 out of 9 and its Altman Z-score is 2.29 (grey zone) for fiscal 2025.